Exumbra development OÜ

Active Registry code 16189330 OÜ Kuressaare linn Registered 22 Mar 2021
Compare

Exumbra development OÜ is a OÜ based in Kuressaare linn, registry code 16189330, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2021 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
02550751001252021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202502550751001252021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 0 € · industry median 0 € · above 40% of the industry
0.00.20.40.60.81.02021 Company: 0 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250.00.20.40.60.81.02021 Company: 0 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 2 500 € · +0.0% vs 2024
05001 0001 5002 0002 5002021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 2 500 €20242025 Company: 2 500 €202505001 0001 5002 0002 5002021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 2 500 €2025 Company: 2 500 €2025
Equity, € 2025: 2 500 € · +0.0% vs 2024
05001 0001 5002 0002 5002021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 2 500 €20242025 Company: 2 500 €202505001 0001 5002 0002 5002021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 2 500 €2025 Company: 2 500 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 0 0 2 500 2 500 0
2024 0 0 — 2 500 2 500 0
2023 0 0 — 2 500 2 500 0
2022 0 0 — 2 500 2 500 0
2021 0 0 — 2 500 2 500 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
0.0 %
Net profit / equity
Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 11 Mar 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 27 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 9 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 16 May 2023 Company’s own e-Äriregister
2021 22 Mar 2021 – 31 Dec 2021 17 Jun 2022 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50169632 / 3
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 50169632 / 2
26 Aug 2021
Amendment under Commercial Code § 525 (2) In force
26 Aug 2021
PDF
Ä 50169632
22 Mar 2021
First entry In force
22 Mar 2021
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data